Meredith L Greene

Title: Meredith L Greene: Innovator in Hepatitis C Research

Introduction

Meredith L Greene is a prominent inventor based in Detroit, MI (US), known for her significant contributions to the field of viral infection treatment. With a total of 2 patents to her name, she has focused her research on developing innovative compounds for the treatment of hepatitis C virus (HCV) infections.

Latest Patents

Her latest patents include "Inhibitors of HCV NS5B polymerase," which provide compounds and methods useful for treating viral infections, particularly HCV infections and associated diseases. The invention outlines novel compounds, pharmaceutical compositions containing these compounds, and methods for their use in treating or preventing HCV infection. Additionally, the patent details processes and intermediates for the synthesis of these compounds.

Career Highlights

Throughout her career, Meredith has worked with notable companies, including Pharmacia & Upjohn Company. Her work has been instrumental in advancing the understanding and treatment of hepatitis C, showcasing her dedication to medical innovation.

Collaborations

Meredith has collaborated with esteemed colleagues such as Richard Allen Nugent and Jeffrey Allen Pfefferkorn, contributing to a rich exchange of ideas and expertise in her field.

Conclusion

Meredith L Greene's work in developing inhibitors for HCV NS5B polymerase highlights her commitment to addressing viral infections and improving treatment options. Her innovative spirit and collaborative efforts continue to make a significant impact in the medical research community.